[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biotwit1 DKBIO

DKBIO posts on X about acasunlimab, $gmab, in november, ben the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XX -XX%
• X Month XXXXX +51%
• X Months XXXXX -XX%
• X Year XXXXXX +158%

Mentions: X #

• X Week X -XX%
• X Month XX +41%
• X Months XX +12%
• X Year XXX +86%

Followers: XXX #

• X Week XXX -XXXX%
• X Month XXX -XXXX%
• X Months XXX +3.60%
• X Year XXX +26%

CreatorRank: undefined #

Social Influence

Social category influence currencies XX%

Social topic influence acasunlimab #1, $gmab #5, in november 20%, ben 20%, guess 20%, mcap 20%, $zyme 20%, ceo XX%

Top accounts mentioned or mentioned by @theraymyers @geokoutalidis @jodmark11 @jacobplieth @bertrandbio @bymadeleinea

Top Social Posts

Top posts by engagements in the last XX hours

"@jodmark11 @TheRayMyers @geokoutalidis Merus CRC data in November and likely also Acasunlimab at SITC hs ben mentioned many times by Gmab. Believe there is some 20+ abstracts on Epcoritamab at ASH too. Read the company presentation"
X Link 2025-09-30T14:15Z XXX followers, XXX engagements

"@JacobPlieth @BertrandBio @ByMadeleineA $GMAB GEN1046 Acasunlimab news SOON. Something like this. PD-L14-1BB gives costimulation but INCOMPLETE PD-1 blockade. Adding a PD-1 inhibitor fully releases inhibition. Together they provide activation plus costimulation driving durable immunity. Guess U knew this by now :-)"
X Link 2025-10-08T12:35Z XXX followers, XXX engagements

"$Gmab Should have kept partnership with Gmab on Acasunlimab. BioNTechs phase X PRESERVE-003 which is assessing CTLA-4 inhibitor gotistobart (also known as BNT316/ONC-393) in non-small cell lung cancer has been put on hold by FDA"
X Link 2024-10-18T21:03Z XXX followers, XXX engagements

"@TheRayMyers @geokoutalidis They are lining up Epkinly developing as planned aim to X L DLBCL and FL as well as Rina-s with great data. Look out for acasunlimab data in nsclc in H2. $Gmab seems on track. Current mcap is a joke"
X Link 2025-08-14T19:01Z XXX followers, XXX engagements

"$ZYME good data on FRa ADC ZW191 in gynecological cancer last week. Genmab bought Profound Bio to get hands on Rinatabart Sesutecan Rina-S for $XXX Bn profound Bios FRa ADC. Gmab CEO told media that several BP CEOs called him to congratulate him on the deal = buyers of Zyme 🔥"
X Link 2025-10-31T18:16Z XXX followers, XXX engagements